Asymptomatic Visceral Leishmaniasis, Northern Israel

Asymptomatic human visceral leishmaniasis was identified in Israel by using an enzyme-linked immunosorbent assay. Positive serum samples were more prevalent in visceral leishmaniasis–endemic (2.97%) compared to nonendemic (1.01%) regions (p=0.021). Parasite exposure was higher than expected, despite...

Descripción completa

Detalles Bibliográficos
Autores principales: Adini, Irit, Ephros, Moshe, Chen, Jacopo, Jaffe, Charles L.
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2003
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958537/
https://www.ncbi.nlm.nih.gov/pubmed/12643842
http://dx.doi.org/10.3201/eid0903.020297
_version_ 1782188358904053760
author Adini, Irit
Ephros, Moshe
Chen, Jacopo
Jaffe, Charles L.
author_facet Adini, Irit
Ephros, Moshe
Chen, Jacopo
Jaffe, Charles L.
author_sort Adini, Irit
collection PubMed
description Asymptomatic human visceral leishmaniasis was identified in Israel by using an enzyme-linked immunosorbent assay. Positive serum samples were more prevalent in visceral leishmaniasis–endemic (2.97%) compared to nonendemic (1.01%) regions (p=0.021). Parasite exposure was higher than expected, despite the small number of clinical cases, suggesting factors other than infection per se influence clinical outcome.
format Text
id pubmed-2958537
institution National Center for Biotechnology Information
language English
publishDate 2003
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-29585372010-10-27 Asymptomatic Visceral Leishmaniasis, Northern Israel Adini, Irit Ephros, Moshe Chen, Jacopo Jaffe, Charles L. Emerg Infect Dis Dispatch Asymptomatic human visceral leishmaniasis was identified in Israel by using an enzyme-linked immunosorbent assay. Positive serum samples were more prevalent in visceral leishmaniasis–endemic (2.97%) compared to nonendemic (1.01%) regions (p=0.021). Parasite exposure was higher than expected, despite the small number of clinical cases, suggesting factors other than infection per se influence clinical outcome. Centers for Disease Control and Prevention 2003-03 /pmc/articles/PMC2958537/ /pubmed/12643842 http://dx.doi.org/10.3201/eid0903.020297 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Adini, Irit
Ephros, Moshe
Chen, Jacopo
Jaffe, Charles L.
Asymptomatic Visceral Leishmaniasis, Northern Israel
title Asymptomatic Visceral Leishmaniasis, Northern Israel
title_full Asymptomatic Visceral Leishmaniasis, Northern Israel
title_fullStr Asymptomatic Visceral Leishmaniasis, Northern Israel
title_full_unstemmed Asymptomatic Visceral Leishmaniasis, Northern Israel
title_short Asymptomatic Visceral Leishmaniasis, Northern Israel
title_sort asymptomatic visceral leishmaniasis, northern israel
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2958537/
https://www.ncbi.nlm.nih.gov/pubmed/12643842
http://dx.doi.org/10.3201/eid0903.020297
work_keys_str_mv AT adiniirit asymptomaticvisceralleishmaniasisnorthernisrael
AT ephrosmoshe asymptomaticvisceralleishmaniasisnorthernisrael
AT chenjacopo asymptomaticvisceralleishmaniasisnorthernisrael
AT jaffecharlesl asymptomaticvisceralleishmaniasisnorthernisrael

Ejemplares similares